Objective: To develop a descriptive model of preventability for maternal morbidity and mortality that can be used in quality assurance and morbidity and mortality review processes.
Introduction
During this century, maternal mortality in the US has fallen dramatically from 900 deaths per 100 000 live births in 1900 to 7.5 per 100 000 live births in 1982. 1, 2 This decline was due mostly to medical and technological advances, as well as efforts on the part of local, state, and federal health systems to identify, review, and analyze cases of maternal mortality. These surveillance systems have succeeded in identifying the causes of maternal death and recognizing large disparities between groups. 3 However, since 1982, the National Center for Health Statistics (NCHS) has reported that the Maternal Mortality Ratio (MMR) in the US has remained steadfastly between seven and eight maternal deaths per 100 000 lives births for deaths that occur within 42 days of delivery or termination of pregnancy. 1, 4 In addition, morbidity (illness during pregnancy or postpartum) when considered jointly with maternal deaths represents a significant health burden, as these conditions are estimated to affect 1.7 million women per year. 5 While the overall number of maternal deaths is low compared to numbers seen in the beginning of the century or in developing countries, the fact that the rate has not declined in 23 years may indicate a need for new approaches to addressing this issue. This need is all the more apparent considering that investigations show that the maternal mortality rate is underestimated, that certain groups are disproportionately affected, and that many of the deaths may be preventable. 1, [6] [7] [8] Preventability of maternal death and illness can refer to primary prevention of the cause of death, such as prevention of ectopic pregnancy through screening and treatment for sexually transmitted diseases. Alternatively, preventability can refer to institutional, provider, and patient factors that may have ultimately prevented a condition from causing death or severe morbidity, such as timely diagnosis and treatment of severe pre-eclampsia.
Until now, studies of preventability have focused on estimating crude incidence rates. For example, Nannini et al. 8 found that 54% of all pregnancy-associated deaths in Massachusetts between 1990 and 1999 were preventable. This included 46% of injury deaths and 16% of deaths from medical causes. Panting-Kemp et al. 7 found similar results in Chicago between 1992 and 1999, where 36% of all maternal deaths were preventable: 37% of pregnancy-related deaths and 30% of unrelated deaths.
In a previous publication related to this study, we reported that the probability that a woman would progress from severe morbidity to near-miss (life-threatening) morbidity to death was significantly related to whether she had a preventable event. 9 This association between preventable factors and progression to more severe outcomes remained significant even after controlling for clinical diagnosis and sociodemographic factors and was specifically due to provider factors (incomplete or inappropriate management) as opposed to system or patient factors. 9 A woman with near-miss morbidity was more than four times as likely to have had providerrelated preventability factors compared to her counterpart with severe morbidity, while a woman who died was close to two times more likely to have had provider-related preventability factors compared to her counterpart with near-miss morbidity. This is critically important because it means that changes in provider decision-making could reduce the severity of disease experienced by high-risk women.
Comprehensive studies of the types of preventable events that occur have yet to appear in maternal mortality research. In order to gain a clearer picture of what role preventability plays in the unchanging maternal mortality rate, an in-depth exploration of how preventability affects maternal mortality and morbidity is required. The primary objective of this descriptive study was to explore in detail the issue of the preventability of maternal mortality and morbidity by identifying and categorizing preventable events occurring to women with severe maternal health problems. The ultimate goal of this study is to present an initial framework for the quantification of preventability that may be used for future research and quality assurance efforts.
Methods
This descriptive study was part of a larger study conducted at the University of Illinois Medical Center at Chicago (UIMC), a tertiary care and Regionalized Perinatal Network center, which coordinates maternal and neonatal services for 10 hospitals. The hospital serves a predominantly African American and Latina population and has approximately 2200 births per year. The larger study used a case control design to select pregnancyrelated deaths, women with near-miss morbidity, and women with severe, but not life threatening, morbidity for analysis. Institutional Review Board approval was granted by the University. For the purposes of this sub-study on preventability, the data from the larger study were used for a descriptive examination to identify and categorize different types of preventable events.
Maternal deaths were identified through state-mandated maternal death reports from the 10 hospitals in the UIMC Perinatal Network for 1992 to 2001. Maternal death was defined as a pregnancy-related death (due to direct or indirect complications of pregnancy) or pregnancy-associated death (e.g., trauma or injury) occurring during the prenatal period or within 90 days following delivery or termination of pregnancy. This was the definition used by the state of Illinois during the study time period.
Maternal morbidities were identified from a variety of data types at the UIMC from 1995 to 2001, including the hospital discharge database, hospital and departmental quality assurance reports, maternal transport logs, and provider referral. Using these sources, women with severe and near-miss maternal morbidity were selected as controls by a team of clinicians, including two Registered Nurses, three Maternal Fetal Medicine physicians, and one PhD researcher with a specialty in maternal health. The overall study sample included 237 women (51 deaths and 186 severe and nearmiss morbidities). More extensive description of the study design and sample selection have been detailed in previous publications. [9] [10] [11] After identifying preventability as a key variable in severe outcomes (death and near-miss morbidity), we carried out a descriptive study of preventability using the 237 women from the study. The goal of this sub-study was to conduct a pilot study for identifying and categorizing types of preventable events. For the purposes of this sub-study, we compared women with preventable events to women without preventable events. This was not the initial study design, but rather was used as a post hoc descriptive study design.
The medical records were reviewed by the team of experts in order to arrive at consensus on classification of each death or morbidity as preventable or not preventable. Preventability was defined as any action or inaction on the part of the healthcare provider, system, or patient that may have caused or contributed to progression to more severe morbidity or death. For this study, therefore, preventability does not necessarily mean that the medical condition itself was preventable, but rather that a woman's outcome might have been less severe were it not for the preventable event. For example, while pre-eclampsia may not have been preventable, progression from mild to severe pre-eclampsia or eclampsia might have been avoided.
Details describing preventable events as discussed by the clinicians were recorded and entered into a Microsoft Access database in text fields. In qualitative analysis, themes (such as 'failure to order labs' or 'delay in treatment') were summarized from the text fields. Headings were then used to group themes that occurred at the same time (such as point of entry to care) or in a similar context (such as management hierarchy). Themes were then organized by chronological occurrence during the progression of illness and care process. A descriptive model was developed in the form of a flow chart based on these headings and their themes.
In quantitative analysis, frequencies of the types of preventable events were calculated. Additionally, characteristics of the sample (age, race/ethnicity, parity, gestational age at delivery, insurance status, and severity of maternal outcome) were compared between women with and without preventable events. w 2 and t-tests were used where appropriate.
Results
Of the 237 women that were enrolled in the larger study, 79 women (33%) had at least one event that was determined to be preventable by the team of experts. Table 1 shows the characteristics of the 79 women with preventable events and the 158 women without preventable events. There was a significant difference (P ¼ 0.001) between the severity of the women's outcomes between groups. Women with preventable events were more likely to experience a near-miss morbidity or a death than women without a preventable event. Differences in average age, percentage of teens and women of advanced maternal age, race/ethnicity, parity, gestational age at delivery, and insurance status were nonsignificant.
As seen in Table 2 , the results of the qualitative analysis for provider and system-related preventability centered around 10 broad chronological/context categories, each of which had multiple themes. Table 2 shows the categories in an approximation of chronological order beginning with a women's point of entry to care, progressing through diagnosis and treatment, and ending with discharge. Other provider and system-related factors that may affect the woman's care are included in the model prior to discharge. There were eight provider-related categories and two system-related categories. Patient factors accounted for only 13-20% (depending on severity of condition) of all preventable events and are not discussed in this paper but have been previously reported. Figure 1 shows the frequencies of the types of preventable events. The most common types of preventable events were related to inadequate diagnosis/recognition of high-risk (54.4%), inappropriate treatment (38.0%), and inadequate documentation (30.7%). The majority of events (77%) in the category of inadequate diagnosis/recognition of high-risk were due to a failure on the part of the provider to diagnose or to recognize the high-risk nature of the condition. The majority of the events (53%) in the category of inappropriate treatment were due to a delay in treatment. 
Comment
The descriptive model of preventability illustrated in this paper was intended to identify and categorize the types of preventable events that occurred in this hospital-based setting but are not unlike those of other tertiary care centers. The goal was to use the data on preventable events to form an evidence-based model that can be used by clinical departments and hospitals to categorize preventable events in maternal morbidity and mortality. To this end, the frequencies of the types of preventable events that occurred in this study were calculated as an example of how this model may be used. In this sample, we saw that the most common types of preventable events were inadequate or inappropriate diagnosis/ recognition of high risk, inappropriate treatment, and inadequate documentation. It will be interesting to see if similar results are obtained when the model is applied to different providers and a different set of patients in different care settings. Interestingly, these results highlight a potential causal chain wherein poor diagnosis may lead to inappropriate or inadequate treatment, or even absence of treatment. Inadequate charting may reflect indecision in both diagnosis and treatment options. For example, if the diagnosis documented in the chart is mild preeclampsia when the patient truly has severe pre-eclampsia then the treatment may be inappropriate. This hypothesis is consistent with results of a study that was performed in this same population regarding the accuracy of ICD-9 codes for pre-eclampsia and eclampsia found in the discharge data. 12 The study found that 41% of all patients had diagnostic coding errors. Lack of provider specificity in diagnosis and charting was the most common reason for incorrect ICD-9 coding. The results of this study using the preventability model confirm the results from the ICD-9 study in that inadequate diagnosis and poor charting were found to be important factors in both studies. Clearly, educational efforts on improving accurate and specific documentation and accurate diagnosis are warranted. Use of this preventability model may also be a mechanism to identify such problems without a full-scale ICD-9 validation study.
Documentation alone is also a crucial category because it may be at the start of a cascade of preventable events. If the diagnosis is not correctly documented in the chart, then treatment errors may inevitably follow. For example, one woman in the study had a suspected ectopic pregnancy that was not correctly documented. The failure to document her suspected diagnosis led to a delay in ordering an ultrasound exam. Her ectopic ruptured and she hemorrhaged, all of which may have been prevented if the initial documentation had been correct.
This study has a number of limitations. First, it is limited by the fact that it was not part of the initial study design. Any descriptive study using post hoc analysis suffers from both external and internal validity limitations. The results cannot be generalized to any larger group of women. Even within the confines of this study, women were not selected based on their preventability status. Therefore, potential selection biases include over or under representation of the true incidence of preventable events within the community. Since a convenience sample of women who both had severe outcomes and preventable events was used, we cannot adequately address the women who had preventable events but no adverse outcomes. Therefore, odds ratios and rates of death cannot be calculated for specific kinds of preventable events. Power analyses for the larger study did not include the number of subjects needed to detect significance for categories of preventability because these categories were deduced from the data. Therefore, the results of this study can be used as a jumping off point for future research and validation. Any such validation should also include inter-rater reliability to test the reproducibility of results using the model.
An in-depth exploration of preventability is crucial to understanding the reasons why the MMR has not declined in 23 years despite medical advances. Without a thorough examination of preventability, it is likely that we will not see major changes in the MMR in the future. The proposal of this model is one step in developing and refining a theory of preventability in maternal morbidity and mortality. The ultimate goal is to produce a model that can be incorporated into quality assurance, clinical case review, and epidemiologic studies to enhance the monitoring of hospital-based obstetric care, to improve estimates of preventable cases, and to decrease medical error. Application in other clinical settings is an important next step in validating and improving the model. Testing the model with other providers and in other institutions will provide measures of reliability and validity that can be used to determine the practical value of this model in other populations. Figure 1 Types of preventable events*. *Event could be categorized under more than one theme; therefore, numbers may add up to more than total. **Provider-related categories. *** System-related categories.
